Frontiers in Biomedicine: Pr Amin Rostami-Hodjegan
03.04.2025 12:30 – 13:30
«Pharmacotherapy Care for All Types of Patients: At the Verge of Impossibility»
Between-patient variability in drug response is a major clinical challenge, often leading to cases of adverse drug reactions or lack of therapeutic efficacy. Dealing with such variability across patient subpopulations effectively within the framework of model-informed precision dosing (MIPD) requires sufficient patient characterization compatible with predictive systems pharmacology modeling platforms. This chapter examines existing and novel patient characterisation approaches, and the tools and models required to implement stratified and individualised precision dosing in clinical studies.
Lieu
Bâtiment: CMU
Auditoire Müller
Organisé par
Département de médecineDépartement d'anesthésiologie, pharmacologie, soins intensifs et urgences
Décanat Faculté de médecine
Evénements de la Faculté de médecine
Centre facultaire d’investigation translationnelle en biomarqueurs (CITB)
Intervenant-e-s
Pr Amin Rostami-Hodjegan, Professor of Systems Pharmacology & Director of Centre for Applied Pharmacokinetics Research, The University of Manchester, UK & Senior Vice-President of R&D and Chief Scientific Officer, Certara, Radnor, Philadelphia, USAentrée libre
Fichiers joints
 | afficheA3_FIB_Rostami_2.pdf | 160.9 Kb |
haut